Appointment of Chief Commercial Officer to Further Advance the Commercialisation of ValiRx Plc'sPortfolio of Innovative Technologies
2/21/2013 9:54:59 AM
More...
|
ValiRx Plc Release: Appointment of Medical Monitoring Officer and VAL201 Update
1/23/2013 10:51:54 AM
More...
|
ValiRx Plc Release: Half Yearly Report
9/20/2012 10:19:08 AM
More...
|
ValiRx Plc Release: VAL201 Update Regarding Breast Cancer Study
9/6/2012 11:44:48 AM
More...
|
ValiRx Plc Release: GeneICE and Biomarkers Development Update
8/2/2012 10:13:03 AM
More...
|
ValiRx Plc's Late Pre-clinical Study of VAL201
5/29/2012 9:38:37 AM
More...
|
New US Patent Grant for ValiRx Plc's Cancer Screening Gene Biomarker
5/15/2012 9:42:39 AM
More...
|
ValiRx Plc Release: Final Results and Notice of AGM
4/27/2012 11:05:30 AM
More...
|
ValiRx Plc Release: Placing of GBP 900,000 and Director's Dealing
4/2/2012 9:00:30 AM
More...
|
ValiRx Plc Release: Material Transfer Agreement Concluded With the Institut Paoli & Calmettes ("IPC") in Marseilles, France to Progress Lead Compound, VAL201, Through Clinical Trials
3/29/2012 9:48:56 AM
More...
|
|